Curaleaf Holdings (CURLF) Gains from Investment Securities (2019 - 2024)

Curaleaf Holdings (CURLF) recorded quarterly Gains from Investment Securities of $6.7 million in Q4 2024, up 293.67% quarter-over-quarter from $1.7 million in Q3 2024, and down 38.11% on a YoY basis from $10.7 million in Q1 2024.

Curaleaf Holdings (CURLF) Gains from Investment Securities (2019 - 2024) Analysis & Trends

Curaleaf Holdings' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $6.7 million for Q4 2024.

  • In Q4 2024, Gains from Investment Securities fell 38.11% year-over-year to $6.7 million; the TTM figure through Dec 2024 stood at $39.5 million (up 40.08% YoY), while the FY2025 annual figure was $888000.0, down 76.79% from the prior year.
  • Gains from Investment Securities was $6.7 million for Q4 2024 at Curaleaf Holdings, up from $1.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $107.6 million in Q3 2023 to a low of -$75.9 million in Q3 2021.
  • Historically, Gains from Investment Securities has averaged $14.5 million across 5 years, with a median of $6.7 million in 2024.
  • The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities tumbled 815.71% in 2021, then surged 73786.3% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $27.0 million in 2020, then plunged by 110.41% to -$2.8 million in 2021, then surged by 826.43% to $20.4 million in 2022, then tumbled by 47.29% to $10.7 million in 2023, then plunged by 38.11% to $6.7 million in 2024.
  • The last three Gains from Investment Securities figures came in at $6.7 million (Q4 2024), $1.7 million (Q3 2024), and $10.7 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Curaleaf Holdings - - 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 6.65 Mn
Dec 31, 2024 6.65 Mn
Sep 30, 2024 1.69 Mn
Sep 30, 2024 1.69 Mn
Dec 31, 2023 10.75 Mn
Dec 31, 2023 10.75 Mn
Sep 30, 2023 107.58 Mn
Sep 30, 2023 107.58 Mn
Dec 31, 2022 20.39 Mn
Dec 31, 2022 20.39 Mn
Sep 30, 2022 -146,000.00
Sep 30, 2022 -146,000.00
Dec 31, 2021 -2.81 Mn
Dec 31, 2021 -2.81 Mn
Sep 30, 2021 -75.91 Mn
Sep 30, 2021 -75.91 Mn
Jun 30, 2021 82.76 Mn
Jun 30, 2021 82.76 Mn
Mar 31, 2021 -171,000.00
Mar 31, 2021 -171,000.00